None listed
Conditions
Interventions
Drug : Patient in the propofol group is supplied with FiO2 40% oxygen at 6 L/min using a face mask. Propofol is injected at 0.8~1.5 mcg/ml as a target controlled infusion, and remifentanil is injected
Sponsors
Asan Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients planning to undergo ultrasound-guided liver radiofrequency ablation under supervised anesthesia 2) Adult male and female patients between the ages of 20 and 80 3) Patients who voluntarily consented in writing to participate in this clinical trial 4) Patients falling under ASA classification 1-2
Exclusion criteria
Exclusion criteria: 1) If the patient does not consent to participate in the study 2) If you have previously been allergic to propofol or remimazolam 3) If the modified Allen's test is negative 4) In case of serious cardiovascular or cerebrovascular disease 5) If you have serious lung disease 6) In case of severe liver cirrhosis 7) Other patients determined by the researcher to be inappropriate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ABGA | — |
Secondary
| Measure | Time frame |
|---|---|
| Vital signs;Iowa satisfaction with anesthesia scale | — |
Countries
Korea, Republic of
Contacts
Public ContactGo Wun Kim
Asan Medical Center
Outcome results
None listed